Inhibiting the proton pump: mechanisms, benefits, harms, and questions

por Aronson, Jeffrey K.
Publicado 2016

Medicines legislation and regulation in the United Kingdom 1500‐2020

por Ferner, Robin E., Aronson, Jeffrey K.
Publicado 2022

Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)—variants in the spellings of drug names in PubMed: a database review

por Ferner, Robin E, Aronson, Jeffrey K
Publicado 2016

Me‐too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists

por Aronson, Jeffrey K., Green, A. Richard
Publicado 2020

Problems with using mechanisms to solve the problem of extrapolation

por Howick, Jeremy, Glasziou, Paul, Aronson, Jeffrey K.
Publicado 2013

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials

por Derry, Sheena, Kong Loke, Yoon, Aronson, Jeffrey K
Publicado 2001

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature

por Sartori, Daniele, Aronson, Jeffrey K., Onakpoya, Igho J.
Publicado 2020

Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis

por Onakpoya, Igho J, Heneghan, Carl J, Aronson, Jeffrey K
Publicado 2015

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

por Onakpoya, Igho J., Heneghan, Carl J., Aronson, Jeffrey K.
Publicado 2016

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review

por Onakpoya, Igho J., Heneghan, Carl J., Aronson, Jeffrey K.
Publicado 2016

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

por Onakpoya, Igho J., Heneghan, Carl J., Aronson, Jeffrey K.
Publicado 2019

The Oxford Catalogue of Opioids: A systematic synthesis of opioid drug names and their pharmacology

por Richards, Georgia C., Sitkowski, Konrad, Heneghan, Carl, Aronson, Jeffrey K.
Publicado 2021

A systematic literature review of LASA error interventions

por Bryan, Rachel, Aronson, Jeffrey K., Williams, Alison J., Jordan, Sue
Publicado 2020

The importance of using placebo controls in nonpharmacological randomised trials

por Wartolowska, Karolina A., Hohenschurz-Schmidt, David, Vase, Lene, Aronson, Jeffrey K.
Publicado 2023

Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity

por Ferner, Robin E., Stevens, Richard J., Anton, Christopher, Aronson, Jeffrey K.
Publicado 2022

Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories

por Richards, Georgia C, Aronson, Jeffrey K, Mahtani, Kamal R, Heneghan, Carl
Publicado 2021

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature

por Sartori, Daniele, Aronson, Jeffrey K., Norén, G. Niklas, Onakpoya, Igho J.
Publicado 2022

Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names

por Bryan, Rachel, Aronson, Jeffrey K., ten Hacken, Pius, Williams, Alison, Jordan, Sue
Publicado 2015

The use of mechanistic reasoning in assessing coronavirus interventions

por Aronson, Jeffrey K., Auker‐Howlett, Daniel, Ghiara, Virginia, Kelly, Michael P., Williamson, Jon
Publicado 2020

The use of mechanistic evidence in drug approval

por Aronson, Jeffrey K., La Caze, Adam, Kelly, Michael P., Parkkinen, Veli‐Pekka, Williamson, Jon
Publicado 2018